vs
Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $172.2M, roughly 1.2× Acadian Asset Management Inc.). Acadian Asset Management Inc. runs the higher net margin — 20.2% vs 8.3%, a 11.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 2.6%). Over the past eight quarters, Acadian Asset Management Inc.'s revenue compounded faster (27.6% CAGR vs 19.1%).
United Asset Management was an American holding company headquartered in Boston, Massachusetts.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
AAMI vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $172.2M | $205.4M |
| Net Profit | $34.7M | $17.0M |
| Gross Margin | — | 62.5% |
| Operating Margin | 33.3% | 29.6% |
| Net Margin | 20.2% | 8.3% |
| Revenue YoY | 2.6% | 12.9% |
| Net Profit YoY | -18.4% | 35.3% |
| EPS (diluted) | $0.97 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $172.2M | $205.4M | ||
| Q3 25 | $144.2M | $209.4M | ||
| Q2 25 | $127.4M | $188.0M | ||
| Q1 25 | $119.9M | $177.8M | ||
| Q4 24 | $167.8M | $181.9M | ||
| Q3 24 | $123.1M | $159.3M | ||
| Q2 24 | $109.0M | $145.3M | ||
| Q1 24 | $105.7M | $144.9M |
| Q4 25 | $34.7M | $17.0M | ||
| Q3 25 | $15.1M | $31.5M | ||
| Q2 25 | $10.1M | $12.0M | ||
| Q1 25 | $20.1M | $2.4M | ||
| Q4 24 | $42.5M | $12.5M | ||
| Q3 24 | $16.9M | $9.3M | ||
| Q2 24 | $11.0M | $19.6M | ||
| Q1 24 | $14.6M | $27.7M |
| Q4 25 | — | 62.5% | ||
| Q3 25 | — | 61.7% | ||
| Q2 25 | — | 57.7% | ||
| Q1 25 | — | 54.8% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 60.8% | ||
| Q2 24 | — | 62.5% | ||
| Q1 24 | — | 63.1% |
| Q4 25 | 33.3% | 29.6% | ||
| Q3 25 | 18.4% | 29.7% | ||
| Q2 25 | 12.7% | 18.7% | ||
| Q1 25 | 26.6% | 12.2% | ||
| Q4 24 | 38.7% | 20.9% | ||
| Q3 24 | 21.9% | 21.9% | ||
| Q2 24 | 18.9% | 32.7% | ||
| Q1 24 | 21.7% | 34.1% |
| Q4 25 | 20.2% | 8.3% | ||
| Q3 25 | 10.5% | 15.0% | ||
| Q2 25 | 7.9% | 6.4% | ||
| Q1 25 | 16.8% | 1.4% | ||
| Q4 24 | 25.3% | 6.9% | ||
| Q3 24 | 13.7% | 5.9% | ||
| Q2 24 | 10.1% | 13.5% | ||
| Q1 24 | 13.8% | 19.1% |
| Q4 25 | $0.97 | $0.48 | ||
| Q3 25 | $0.42 | $0.84 | ||
| Q2 25 | $0.28 | $0.34 | ||
| Q1 25 | $0.54 | $0.07 | ||
| Q4 24 | $1.11 | $0.36 | ||
| Q3 24 | $0.45 | $0.27 | ||
| Q2 24 | $0.29 | $0.52 | ||
| Q1 24 | $0.37 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $386.7M |
| Total DebtLower is stronger | $200.0M | — |
| Stockholders' EquityBook value | — | $301.7M |
| Total Assets | $677.0M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $386.7M | ||
| Q3 25 | — | $285.9M | ||
| Q2 25 | — | $222.2M | ||
| Q1 25 | — | $197.8M | ||
| Q4 24 | — | $162.8M | ||
| Q3 24 | — | $120.0M | ||
| Q2 24 | — | $271.6M | ||
| Q1 24 | — | $318.0M |
| Q4 25 | $200.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $275.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $301.7M | ||
| Q3 25 | — | $274.8M | ||
| Q2 25 | — | $232.2M | ||
| Q1 25 | — | $234.4M | ||
| Q4 24 | — | $228.8M | ||
| Q3 24 | — | $234.3M | ||
| Q2 24 | — | $216.6M | ||
| Q1 24 | — | $222.2M |
| Q4 25 | $677.0M | $1.7B | ||
| Q3 25 | $751.4M | $1.6B | ||
| Q2 25 | $672.3M | $1.6B | ||
| Q1 25 | $677.3M | $1.6B | ||
| Q4 24 | $703.2M | $1.7B | ||
| Q3 24 | $555.2M | $1.6B | ||
| Q2 24 | $533.1M | $1.1B | ||
| Q1 24 | $544.9M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.4M | $123.0M |
| Free Cash FlowOCF − Capex | — | $122.4M |
| FCF MarginFCF / Revenue | — | 59.6% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | -0.07× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | — | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.4M | $123.0M | ||
| Q3 25 | $-23.9M | $78.4M | ||
| Q2 25 | $61.6M | $72.4M | ||
| Q1 25 | $-48.8M | $55.4M | ||
| Q4 24 | $55.8M | $84.6M | ||
| Q3 24 | $69.6M | $-9.0M | ||
| Q2 24 | $45.7M | $67.4M | ||
| Q1 24 | $-40.4M | $61.9M |
| Q4 25 | — | $122.4M | ||
| Q3 25 | — | $78.3M | ||
| Q2 25 | — | $72.4M | ||
| Q1 25 | — | $54.6M | ||
| Q4 24 | — | $84.1M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $67.1M | ||
| Q1 24 | — | $61.4M |
| Q4 25 | — | 59.6% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 30.7% | ||
| Q4 24 | — | 46.2% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | — | 46.2% | ||
| Q1 24 | — | 42.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | -0.07× | 7.25× | ||
| Q3 25 | -1.58× | 2.49× | ||
| Q2 25 | 6.10× | 6.05× | ||
| Q1 25 | -2.43× | 22.92× | ||
| Q4 24 | 1.31× | 6.75× | ||
| Q3 24 | 4.12× | -0.96× | ||
| Q2 24 | 4.15× | 3.44× | ||
| Q1 24 | -2.77× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
